Skip to main content
. 2022 Sep;63(9):1371–1377. doi: 10.2967/jnumed.121.263177

TABLE 2.

Proportion of Patients with uPAR PET–Positive Tumors by WHO Grade

Parameter G1 (n = 21) G2 (n = 51) G3 (n = 24) Overall (n = 96)
uPAR PET–positive 12 (57%) 35 (69%) 18 (75%) 65 (68%)

Data are number followed by percentage in parentheses. uPAR TLR was used to define lesions as uPAR-positive when lesion SUVmax–to–normal-liver SUVmean was ≥2. Of patients with G3, 8 of 9 NET G3 and 10 of 15 NEC were uPAR PET–positive.